Current Report Filing (8-k)
February 17 2017 - 7:16AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
______________
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported):
February
17, 2017
______________
LIFEPOINT
HEALTH, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
000-51251
|
20-1538254
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
330 Seven Springs Way
Brentwood, Tennessee
|
37027
|
(Address
of principal executive offices)
|
(Zip
Code)
|
615-920-7000
(
Registrant’s
telephone number, including area code)
N/A
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition.
On February 17, 2017, LifePoint Health, Inc. (the "Company") issued a
press release announcing results for the fourth quarter and year ended
December 31, 2016. See the press release attached as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
|
(d)
|
Exhibits.
|
|
|
|
|
|
99.1 Copy of press release issued by the Company on February
17, 2017.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date:
|
February 17, 2017
|
LIFEPOINT HEALTH, INC.
|
|
|
|
|
|
By:
|
/s/ Michael S. Coggin
|
|
|
|
|
|
|
|
Michael S. Coggin
|
|
|
|
Executive Vice President and Chief Financial Officer
|
EXHIBIT INDEX
Exhibit
Number
|
|
Description
|
|
|
|
99.1
|
|
Copy of press release issued by the Company on February 17, 2017.
|
LifePoint Health, Inc. (NASDAQ:LPNT)
Historical Stock Chart
From Mar 2024 to Apr 2024
LifePoint Health, Inc. (NASDAQ:LPNT)
Historical Stock Chart
From Apr 2023 to Apr 2024